Fundviser Capit. (530197)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹138.95 |
| Market Cap | ₹71.82 Cr |
| P/E Ratio | 111.04 |
| ROCE | 0% |
| ROE | 10.94% |
| Dividend Yield | 0% |
| Profit Growth | -26.04% |
| Debt/Equity | — |
| Sales Growth | 676.55% |
| 52-Week Range | ₹179.5 — ₹484.4 |
| Sector | Finance |
| Book Value | ₹19.49 |
Strengths
- Latest quarter sales of ₹51 Cr show meaningful top-line activity
- Sales growth of 676.55% indicates rapid expansion from a small base
- ROE of 10.94% shows some shareholder value generation
- Latest quarter net profit of ₹2 Cr proves basic profitability
Concerns
- P/E of 111.04 and P/B of 7.13 imply extreme valuation against book value and earnings
- Profit growth declined 26.04% despite explosive sales growth, suggesting margin pressure
- Piotroski F-score of 3/9 signals weak financial health
- Zero dividend yield and 0% ROCE offer no return on capital or shareholder income
AI Analysis
When I look at Fundviser Capit., I see a small investment company with a market cap of just ₹72 Cr. The share price of ₹138.95 is actually below its 52-week low of ₹155.60, which tells me the market is currently rejecting this stock. As Graham said, the market is there to serve us, not to guide us, but I still need a margin of safety. Here I don't find one. The P/E is 111.04 and the P/B is 7.13, while book value is only ₹19.49. That means I am paying ₹7 for every ₹1 of net assets. The latest quarter shows sales of ₹51 Cr, but net profit is just ₹2 Cr, a razor-thin margin. Yes, sales growth is 676.55%, but profit is down 26.04%. Growth that does not flow to the bottom line is just top-line vanity. ROE of 10.94% is acceptable but unexciting, and ROCE of 0% suggests no real return on capital employed. The Piotroski F-score of 3/9 is a loud warning about financial health. With no dividend and no promoter holding details, I cannot assess insider commitment. The PEG of 0.16 looks cheap, but it is based on past growth that is not continuing. This is not a compounder; it looks like a speculative vehicle. In Benjamin Graham's framework, I want a business with durable earnings power and a reasonable price. This has neither. I will pass and wait for something better.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer